Genius Sports Ltd. (GENI)
NYSE NYSE Primary 
XSTO 
Genius Sports Limited (GENI) Analyst/Investor Day Transcript
Genius Sports Limited (GENI) Analyst/Investor Day Transcript
GENinCode surges on Thermo Fisher deal to roll out heart-disease test
Shares in GENinCode PLC (AIM:GENI) jumped 34% to 4.02p after the predictive genetics group unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific to manufacture, sell and distribute its CARDIO inCode-Score test. The agreement covers the US and the Europe, Middle East and Africa region.
Compared to Estimates, Genius Sports Limited (GENI) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for Genius Sports Limited (GENI) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Genius Sports Limited (GENI) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference Transcript
Genius Sports Limited (NYSE:GENI ) Citi's 2025 Global Technology, Media and Telecommunications Conference September 5, 2025 8:50 AM EDT Company Participants Nicholas Taylor - Chief Financial Officer Conference Call Participants Jason Bazinet - Citigroup Inc., Research Division Presentation Jason Bazinet MD, Global Head of EMT & Analyst Very excited to have Nick Taylor, CFO of Genius Sports. Nick? Nicholas Taylor Chief Financial Officer Yes.
Genius Sports Limited (GENI) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Genius Sports Limited (GENI) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Genius Sports Limited (GENI) Moves 10.6% Higher: Will This Strength Last?
Genius Sports Limited (GENI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Genius Sports Limited (GENI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Genius Sports Limited (GENI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does Genius Sports Limited (GENI) Have the Potential to Rally 26.06% as Wall Street Analysts Expect?
The mean of analysts' price targets for Genius Sports Limited (GENI) points to a 26.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Genius Sports Limited (GENI) Surges 8.4%: Is This an Indication of Further Gains?
Genius Sports Limited (GENI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Genius Sports Limited (GENI) Q1 2025 Earnings Call Transcript
Genius Sports Limited (NYSE:GENI ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Brandon Bukstel - IR Manager Mark Locke - CEO Nicholas Taylor - CFO Conference Call Participants Jordan Bender - Citizens JMP Ryan Sigdahl - Craig-Hallum Capital Group Bernie McTernan - Needham Ben Miller - Goldman Sachs Jed Kelly - Oppenheimer Clark Lampen - BTIG Josh Nichols - B. Riley Chad Beynon - Macquarie Mike Hickey - Benchmark Eric Martinuzzi - Lake Street Capital Markets Operator Thank you for standing by.
Compared to Estimates, Genius Sports Limited (GENI) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Genius Sports Limited (GENI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Genius Sports Limited (GENI) Reports Q1 Loss, Tops Revenue Estimates
Genius Sports Limited (GENI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.11 per share a year ago.
